Hydrochlorothiazide
- Product NDC
- 0527-1635
- 11-digit product format
- 005271635
- Labeler code
- 0527
- Product ID
- 0527-1635_1d8e77d7-2c00-4f9a-bea8-245641d3cd4a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA091662
- Marketing category
- ANDA
- Marketing start
- 2012-01-27
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0527-1635-01 | 2022-10-03 | C162847 | 48780-1 | 9d75b9d0-2bcc-f424-e053-dadaa90a57ce | d90916e8-88c0-4f5e-bbd9-20c5fb075de0 |
| 0527-1635-05 | 2022-10-03 | C162847 | 48780-1 | 9d75b9d0-2bcc-f424-e053-dadaa90a57ce | d90916e8-88c0-4f5e-bbd9-20c5fb075de0 |
| 0527-1635-10 | 2022-10-03 | C162847 | 48780-1 | 9d75b9d0-2bcc-f424-e053-dadaa90a57ce | d90916e8-88c0-4f5e-bbd9-20c5fb075de0 |
| 0527-1635-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2bcc-f424-e053-dadaa90a57ce | d90916e8-88c0-4f5e-bbd9-20c5fb075de0 |
| 0527-1635-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2bcc-f424-e053-dadaa90a57ce | d90916e8-88c0-4f5e-bbd9-20c5fb075de0 |
| 0527-1635-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2bcc-f424-e053-dadaa90a57ce | d90916e8-88c0-4f5e-bbd9-20c5fb075de0 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0527-1635-01 | EA - Each | 0527-1635 | 38aaa6ab-81c9-4399-85b2-f84537c5fd2a | 1 | 2012-07-24 |
| 0527-1635-05 | EA - Each | 0527-1635 | 20bfa372-dc2d-4e64-b856-6e0afe710a8d | 1 | 2012-07-24 |
| 0527-1635-10 | EA - Each | 0527-1635 | 40cc25f7-1d3e-404f-94ee-c326743885b5 | 1 | 2012-07-24 |